Comparative in vitro dissolution studies of fixed-dose combination formulations: analgesic tablets of acetaminophen/caffeine

Medina-López J R; Sánchez-Badajos S; Carreto-Jiménez R M; García-Hernández P; Contreras-Jiménez J M

Medina-López J R ⁽¹⁾ , Sánchez-Badajos S ⁽²⁾ , Carreto-Jiménez R M ⁽³⁾ , García-Hernández P ⁽⁴⁾ , Contreras-Jiménez J M ⁽⁵⁾

(1) Departamento Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico, Mexico ,

(2) Departamento Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico, Mexico ,

(3) Departamento Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico, Mexico ,

(4) Departamento Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico, Mexico ,

(5) Departamento Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico, Mexico

Issue
Vol. 12 No. 2 (2021): Volume 12 Issue 2

Keywords:

Acetaminophen, Caffeine, Flow-through cell apparatus, Generic formulations, USP Apparatus 4

PDF LaTeX HTML epub

Abstract

A simple and rapid UV derivative method with zero-crossing determinations was developed for estimation of acetaminophen (ACE) and caffeine (CAF) in fixed-dose combination formulations. The first-derivative of standard solutions of both drugs were used and ACE and CAF were quantified at 273.0 and 216.5 nm, respectively. The method was validated, and it was applied to dissolution studies with the USP Apparatus 2 and flow-through cell (USP Apparatus 4). Dissolution profiles comparisons (generic vs reference) were carried out with model-independent and model-dependent approaches. Mean dissolution time and dissolution efficiency were calculated and significant differences, in almost all calculated parameters, were found (p<0.05). Weibull, logistic, Gompertz, and Probit models were used to fit dissolution data and Probit was the best-fit model that describes the in vitro dissolution performance of ACE and CAF. Using t_50%data, derived from this fit, dissolution profiles of ACE in USP Apparatus 2 were significant different (p<0.05). The proposed UV derivative method generates reliable information that can be compared with published results. Dissolution studies of fixed-dose combination formulations are important because quality of generic drug products depends on quality of references. It is essential to maintain a post-marketing evaluation of formulations with analgesic drugs mixed with CAF to offer the population high quality medicines.

Full text article

Generated from XML file

References

Adams, E., Coomans, D., Smeyers-Verbeke, J., Massart, D. L. 2002. Non-linear mixed effects models for the evaluation of dissolution profiles. International Journal of Pharmaceutics, 240(1-2):37–53.

Akdag, Y., Gulsun, T., Izat, N., Oner, L., Sahin, S. 2020. Comparison of Dissolution Profiles and Apparent Permeabilities of Commercially Available Metformin Hydrochloride Tablets in Turkey. Dissolution Technologies, 27(1):22–29.

Alvarado, A. T., Muñoz, A. M., Miyasato, J. M., Alvarado, E. A., Loja, B., Villanueva, L., Pineda, M., Bendezú, M., Palomino-Jhong, J. J., García, J. A. 2020. In Vitro Therapeutic Equivalence of Two Multisource (Generic) Formulations of Sodium Phenytoin (100 mg) Available in Peru. Dissolution Technologies, 27(4):33–40.

Ameri, M. N. A., Nayuni, N., Kumar, K. A., Perrett, D., Tucker, A., Johnston, A. 2012. The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing. Results in Pharma Sciences, 2:1–8.

Anderson, N. H., Bauer, M., Boussac, N., Khan-Malek, R., Munden, P., Sardaro, M. 1998. An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. Journal of Pharmaceutical and Biomedical Analysis, 17(4- 5):811–822.

Brown, W. 2005. Apparatus 4 Flow Through Cell: Some Thoughts on Operational Characteristics. Dissolution Technologies, 12(2):28–30.

Cardot, J.-M., Beyssac, E., Alric, M. 2007. In Vitro–In Vivo Correlation: Importance of Dissolution in IVIVC. Dissolution Technologies, 14(1):15–19.

Cofepris, L. 2020. Listado actualizado de medica-mentos de referencia 2020/01. Mexico, Accessed on: 21 Jan 2021.

D’Arcy, D. M., Liu, B., Bradley, G., Healy, A. M., Corrigan, O. I. 2010. Hydrodynamic and Species Transfer Simulations in the USP 4 Dissolution Apparatus: Considerations for Dissolution in a Low Velocity Pulsing Flow. Pharmaceutical Research, 27(2):246–258.

Dinç, E. 1999. A comparative study of the ratio spectra derivative spectrophotometry, Vierordt’s method and high-performance liquid chromatography applied to the simultaneous analysis of caffeine and paracetamol in tablets. Journal of Pharmaceutical and Biomedical Analysis, 21(4):723– 730.

Fang, J. B., Robertson, V. K., Rawat, A., Flick, T., Tang, Z. J., Cauchon, N. S., McElvain, J. S. 2010. Development and Application of a Biorelevant Dissolution Method Using USP Apparatus 4 in Early Phase Formulation Development. Molecular Pharmaceutics, 7(5):1466–1477.

FDA 2017. Guidance for Industry. Waiver on in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system. U.S. Department of Health and Human Services. Center for Drug Evaluation and Research (CDER). Accessed on: 21 Jan 2021.

Franek, F., Holm, P., Larsen, F., Steffansen, B. 2014. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine-controlled release tablets: Comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3. International Journal of Pharmaceutics, 461(1-2):419–426.

Gao, Z. 2009. In Vitro Dissolution Testing with Flow-Through Method: A Technical Note. AAPS Pharm SciTech, 10(4):1401–1405.

Hamed, S., Ayob, F. A., Alfatama, M., Doolaanea, A. A. 2017. Enhancement of the Immediate Release of Paracetamol from Alginate Beads. International Journal of Applied Pharmaceutics, 9(2):47–51.

Ichi Jinno, J., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G. G., Higaki, K., Kimura, T. 2008. In vitro–in vivo correlation for wet-milled tablet of poorly water soluble cilostazol. Journal of Controlled Release, 130(1):29–37.

Illangakoon, U. E., Gill, H., Shearman, G. C., Parhizkar, M., Mahalingam, S., Chatterton, N. P., Williams, G.R. 2014. Fast dissolving paracetamol/caffeine nanofibers prepared by electrospinning. International Journal of Pharmaceutics, 477(1-2):369– 379.

Jantratid, E., Maio, V. D., Ronda, E., Mattavelli, V., Vertzoni, M., Dressman, J. B. 2009. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form. European Journal of Pharmaceutical Sciences, 37(3- 4):434–441.

Kalantzi, L., Reppas, C., Dressman, J. B., Amidon, G. L., Junginger, H. E., Midha, K. K., Shah, V. P., Stavchan sky, S. A., Barends, D. M. 2006. Biowaiver monographs for immediate release solid oral dosage forms: Acetaminophen (paracetamol). Journal of Pharmaceutical Sciences, 95(1):4–14.

Liu, X. Z., Liu, S. S., Wu, J. F., Fang, Z. L. 1999. Simultaneous monitoring of aspirin, phenacetin and caffeine in compound aspirin tablets using a sequential injection drug-dissolution testing system with partial least squares calibration. Analytica Chimica Acta, 392(2-3):273–281.

Lokhandwala, H., Deshpande, A., Deshpande, S. 2013. Kinetic modeling and dissolution profiles comparison: an overview. International Journal of Pharma and Bio Sciences, 4(1):728–737.

Looney, T. J. 1997. USP Apparatus 4 - Applying the Technology. Dissolution Technologies, 4(2):16–18.

López, J. R. M., Domínguez-Ramírez, A. M., Cook, J., Bravo, G., Díaz-Reval, M. I., Déciga-Campos, M., López-Muñoz, F. J. 2006. Enhancement of antinociception by co-administration of ibuprofen and caffeine in arthritic rats. European Journal of Pharmacology, 544(1-3):31–38.

Medina, J. R., García, C. A., Hurtado, M., Domínguez-Ramírez, A. M. 2016. Simultaneous determination of ketoprofen and acetaminophen in fixed-dose combination formulations by first-order derivative spectroscopy: application to dissolution studies. International Journal of Pharmacy and Pharmaceutical Sciences, 8(2):244–248.

Medina, J. R., Miranda, M., Hurtado, M., Dominguez- Ramirez, A. M., Ruiz-Segura, J. C. 2013. Simultaneous determination of trimethoprim and sulfamethoxazole in immediate-release oral dosage forms by first-order derivative spectroscopy: Application to dissolution studies. International Journal of Pharmacy and Pharmaceutical Sciences, 5(Supp4):505–510.

Medina, J. R., Salazar, D. K., Hurtado, M., Cortés, A. R., Domínguez-Ramírez, A. M. 2014. Comparative in vitro dissolution study of carbamazepine immediate-release products using the USP paddles method and the flow through cell system. Saudi Pharmaceutical Journal, 22(2):141–147.

Medina-López, J. R., Pineda, J. G. P., et al. 2020. Derivatives of the ratio spectra for determination of acetylsalicylic acid, acetaminophen, and caffeine in fixed-dose combination formulations: application to dissolution studies. International Journal of Applied Pharmaceutics, 12(6):253–257.

Medina-Lopez, R., Reyes-Ibarra, A. D., Hurtado, M. 2019. In Vitro Equivalence Study of Propranolol HCl tablets Using USP Basket Apparatus and Flow Through Cell Method. Latin American Journal of Pharmacy, 38(1):92–101.

Moore, J. W., Flanner, H. H. 1996. Mathematical comparison of dissolution profiles. Pharmaceutical technology, 20(6):64–74.

Podczeck, F. 1993. Comparison of in vitro dissolution profiles by calculating mean dissolution time (MDT) or mean residence time (MRT). International Journal of Pharmaceutics, 97(1-3):93–100.

Ruiz, M. E., Gregorini, A., Talevi, A., Volonté, M. G. 2012. Dissolution Studies of Generic Medications: New Evidence of Deviations from the Transitivity Principle. Dissolution Technologies, 19(1):13–24.

Sawynok, J., Yaksh, T. L. 1993. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacological Reviews, 45(1):43–85.

Shah, V. P., Gurbarg, M., Noory, A., Dighe, S., Skelly, J. P. 1992. Influence of Higher Rates of Agitation on Release Patterns of Immediate-Release Drug Products. Journal of Pharmaceutical Sciences, 81(6):500–503.

Szumilo, M., Belniak, P., Kasperek-Nowakiewicz, R., Holody, E., Poleszak, E. 2019. Comparative’s dissolution studies on granules with acetaminophen and caffeine using the basket and paddle methods with simultaneous spectrophotometric determination of active substances. Current Issues in Pharmacy and Medical Sciences, 32(4):219–224.

Tan, S., Ebrahimi, A., Langrish, T. 2019. Controlled release of caffeine from tablets of spray dried casein gels. Food Hydrocolloids, 88:13–20. United States Pharmacopeial Convention 2019. The United States Pharmacopoeia: USP 42: The National Formulary: NF 37. Rockville, MD. page 52.

Usman, S., Saeed, A., Fatima, S., Ramesh, V., Shah, F., Islam, Q. 2020. In Vitro Bioequivalence of Pregabalin Capsules (150 mg): An Alternative to In Vivo Bioequivalence Studies. Dissolution Technologies, 27(4):24–31.

Varillas, M. A., Brevedan, M. I., Vidal, N. L. G. 2020. Critical Quality Attributes and Pharmaceutical Equivalence Assessment of Allopurinol Tablets in Argentina. Dissolution Technologies, 27(4):15– 22.

Vichare, V., Mujgond, P., Tambe, V., Dhole, S. N. 2010. Simultaneous spectrophotometric determination of paracetamol and caffeine in tablet formulation. International Journal of PharmTech Research, 2(4):2512–2516.

Williams, H. D., Barrett, D. A., Ward, R., Hardy, J., Melia, C. D. 2010. A liquid chromatography method for quantifying caffeine dissolution from pharmaceutical formulations into colloidal, fat-rich media. Journal of Chromatography B, 878(21):1739–1745.

Yoon, E., Babar, A., Choudhary, M., Kutner, M., Pyrsopoulos, N. 2016. Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update. Journal of Clinical and Translational Hepatology, 4(2):131– 142.

Yuksel, N., et al. 2000. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and independent methods. International Journal of Pharmaceutics, 209(1-2):57–67.

Zhang, Y., Huo, M., Zhou, J., Zou, A., Li, W., Yao, C., Xie, S. 2010. DD Solver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles. The AAPS Journal, 12(3):263–271.